Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?

about

The VEGF and PEDF levels in the follicular fluid of patients co- treated with LETROZOLE and gonadotropins during the stimulation cycle.

P2860

Q55365335-AF0DE078-91C8-494C-863C-8F1606978CB3

P2860

Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?

Item

http://www.wikidata.org/entity/Q41571120

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Does daily co-administration o ...... imulation improve IVF outcome?

@en

type

Item

label

Does daily co-administration o ...... imulation improve IVF outcome?

@en

prefLabel

Does daily co-administration o ...... imulation improve IVF outcome?

@en

P1476

Does daily co-administration o ...... imulation improve IVF outcome?

@en

P2093

Eran Barzilay

http://www.w3.org/2001/XMLSchema#string

Jigal Haas

http://www.w3.org/2001/XMLSchema#string

Jim Meriano

http://www.w3.org/2001/XMLSchema#string

Nivin Samara

http://www.w3.org/2001/XMLSchema#string

Noa Gonen

http://www.w3.org/2001/XMLSchema#string

Rawad Bassil

http://www.w3.org/2001/XMLSchema#string

Robert F Casper

http://www.w3.org/2001/XMLSchema#string

P2860

The impact of supraphysiologic serum estradiol levels on peri-implantation embryo development and early pregnancy outcome following in vitro fertilization cycles

Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility

Comparison of IVF Outcomes between Minimal Stimulation and High-Dose Stimulation for Patients with Poor Ovarian Reserve.

Endometrial receptivity defects during IVF cycles with and without letrozole.

The "ART" of thromboembolism: a review of assisted reproductive technology and thromboembolic complications.

The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.

The use of aromatase inhibitors for ovulation induction.

Aromatase inhibitors for ovulation induction.

No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in assisted reproductive technology.

Pregnancy and neonatal outcomes following letrozole use in frozen-thawed single embryo transfer cycles.

P2888

s12958-017-0288-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12958-017-0288-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091371154

http://www.w3.org/2001/XMLSchema#string

P698

28854933

http://www.w3.org/2001/XMLSchema#string

P932

5577762

http://www.w3.org/2001/XMLSchema#string

Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?

about

P2860

P2860

Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932